Results for tag: "Graft Versus Host Disease"

Graft Versus Host Disease (GVHD) is a condition that occurs when the immune cells of a donor (the graft) attack the cells of the recipient (the host). It is a common complication of bone marrow and stem cell transplants, and is a major cause of morbidity and mortality in transplant recipients. GVHD can affect any organ system, including the skin, gastrointestinal tract, liver, and lungs. Symptoms can range from mild to severe, and can include skin rash, abdominal pain, nausea, vomiting, and diarrhea. Treatment of GVHD typically involves immunosuppressive medications, such as corticosteroids, and supportive care. The GVHD market is a subset of the Allergy and Immunology market, and is focused on the diagnosis and treatment of GVHD. Companies in this market include Novartis, Celgene, Gilead Sciences, and Kite Pharma. Show Less Read more